Anti-PD1 versus anti-PD-L1 immunotherapy in first-line therapy for advanced non-small cell lung cancer: A systematic review and meta-analysis

Brito, ABC; Camandaroba, MPG; de Lima, VCC

de Lima, VCC (corresponding author), AC Camargo Canc Ctr, Dept Med Oncol, Sao Paulo, SP, Brazil.

THORACIC CANCER, ; ():

Abstract

Background Due to the increasing number of trials with immune checkpoint inhibitors (ICIs) in the first-line therapy of non-small cell lung cancer (NS......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索